Digital and Real-Time PCR Market Expected to Reach $15.19 Billion by 2031
“Digital PCR and Real-Time PCR Market” in terms of revenue was estimated to be worth USD 8.30 billion in 2023, and it is poised to reach USD 15.19 billion by 2031, growing at a CAGR of 7.97% from 2024 to 2031 according to a new report by InsightAce Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1772
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the digital PCR and real-time PCR Market are:
Increase in the prevalence of chronic illnesses
Consistently improving PCR methods
Increasing rates of specific infectious illnesses
The following are the primary obstacles to the digital PCR and real-time PCR Market's expansion:
High cost
Lack of qualified personnel
Lack of uptake in emerging markets
Future expansion opportunities for the digital PCR and real-time PCR Market include:
Raising PCR’s profile in the search for biomarkers
Increasing investment in research
Rising incidence of hereditary diseases
Market Analysis:
The market for real-time and digital PCR is growing because demand for technologically sophisticated digital PCR and real-time PCR tests is expected to be driven over the forecast period by several factors, such as the successful completion of the human genome project, growth in the usage of biomarker profiling for illness diagnosis, and the rising prevalence of genetic illnesses and major infectious illnesses. The need for digital PCR and real-time PCR is predicted to rise in the coming years due to significant technological breakthroughs, increasing investments, funding, and grants.
List of Prominent Market Players in the Digital PCR and Real-Time PCR Market:
Abbott Laboratories
Agilent Technologies, Inc.
Analytik Jena AG
Becton Dickinson and Company
Bio Molecular Systems
Biomeme Inc.
Biomérieux S.A.
Bioneer Corporation
Bio-Rad Laboratories, Inc.
Cole-Parmer Instrument Company Llc
Danaher Corporation
Elitech Group Sas
Endress+Hauser
Enzo Life Sciences, Inc.
Eppendorf AG
Hoffmann-LA Roche Ltd.
Fluidigm Corporation
JN Medsys PTE, LTD.
Merck KGAA
Meridian Bioscience, Inc.
Promega Corporation
Qiagen N.V.
Quidel Corporation
Quanta Biosciences Inc.
Sacace Biotechnologies Srl
Standard Biotools
Stilla Technologies
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Recent Developments:
In Oct 2022, BioExcel Diagnostics and Takara Bio USA have formed a collaborative alliance with the intention of creating a qPCR multiplex syndromic infectious disease diagnostic panel. qPCR automation technology and reagents supplied by Takara Bio USA, an entirely owned subsidiary of Takara Bio headquartered in Shiga, Japan, were utilized by the panels to identify antimicrobial resistance genes, bacteria, fungi, and viruses.
In Aug 2022, Roche announced the introduction of its first digital polymerase chain reaction (PCR) system, the Digital LightCycler System. Designed to accurately quantify trace quantities of specific DNA and RNA targets that are not ordinarily detectable by conventional PCR techniques, this next-generation system detects disease. Clinical researchers are able to partition DNA and RNA extracted from a pre-existing clinical sample into up to one hundred thousand microscopic individual reactions using the Digital LightCycler System. The results of the PCR can then be subjected to an extremely sophisticated data analysis by the system.
Digital PCR and Real-Time PCR Market Dynamics:
Market Drivers: Increasing Need for Medical Diagnostics
The rising demand for digital and real-time PCR as clinical diagnostic tools is pushing the industry forward, especially in detecting cancer, genetic disorders, and infectious diseases. For early diagnosis and therapy, digital PCR and real-time PCR's capacity to detect infections and genetic alterations quickly, accurately, and sensitively is essential and will play a substantial role as drivers throughout the projection period.
Challenges: A Dearth of Interest in Developing Economies and A Scarcity of Trained Personnel
A major obstacle to the market's growth is in developing nations, problems with infrastructure, reimbursement, and a general lack of understanding is slow the spread of digital PCR and real-time PCR market limiting the potential for growth in these markets. Additionally, there may be a scarcity of trained personnel in certain clinical and laboratory settings who can operate and comprehend the specialized equipment and data generated by real-time PCR and digital PCR processes, limiting the growth of the digital PCR and real-time PCR market.
North America is Expected to Grow with the Highest CAGR During the Forecast Period
The North American digital PCR and real-time PCR Market is likely to register a significant revenue share and also develop at a rapid CAGR in the near future. This is because of the high disease prevalence in the area, favorable regulations, and numerous government initiatives to improve healthcare infrastructure. Additionally, the North American market is expected to be driven by several crucial variables throughout the projection period, including the region’s substantial presence of major producers and a growing demand for rapid tests for illness. Furthermore, advancements in healthcare, research and development, and clinical development frameworks, and the incorporation of digital PCR and real-time PCR methods into emerging economies’ technologies are growing the demand for the real-time PCR market.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1772
Segmentation of Digital PCR and Real-Time PCR Market-
By Product & Service-
QPCR Products & Services
qPCR Reagents and Consumables
qPCR Instruments
qPCR Software and Services
DPCR Products & Services
dPCR Reagents and Consumables
dPCR Instruments
Chip-based Digital PCR
Beaming Digital PCR
DPCR Software and Services
By Application-
Clinical Applications
Infectious Disease Testing
Oncology Testing
Blood Screening
Transplant Diagnostics
Other Clinical Applications
Research Applications
Forensic Applications
Environmental Applications
Others
By End-User-
Hospitals and Diagnostic Laboratories
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
CROs and CDMOs
Forensic Laboratories
Others
By Region-
North America-
The US
Canada
Mexico
Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
China
Japan
India
South Korea
South East Asia
Rest of Asia Pacific
Latin America-
Brazil
Argentina
Rest of Latin America
Middle East & Africa-
GCC Countries
South Africa
Rest of Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/1772
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
